What is Lifitegrast ophthalmic solution?
Category: Prescription Drugs
Most popular types: Xiidra
Lifitegrast ophthalmic solution is a lymphocyte function-associated antigen-1 antagonist that is used to treat dry eye disease.
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Dry eye syndrome | 10 | 5 | |
| Dry eyes | 7 | 2 | |
| Sjogren's syndrome | 3 | 1 | |
| Meibomian gland dysfunction | 1 | 1 | |
| Sjogren-Larsson syndrome | 1 | 0 | |
| Uveitis | 1 | 0 |
- Major
- Moderate
- Slight
- None
- Can't tell
Side effects
Side effects as an overall problem
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 2 | |
| Mild | 2 | |
| None | 4 |
Commonly reported side effects and conditions associated with Lifitegrast ophthalmic solution
| Side effect | Patients | Percentage |
|---|---|---|
| Burning sensation in eyes | 2 | |
| Bad taste in mouth | 1 | |
| Eyes stinging | 1 | |
| Eyes watering (tearing) | 1 | |
| Light sensitivity (photophobia) | 1 |
Why patients stopped taking Lifitegrast ophthalmic solution
Multiple reasons could be selected
| Reason | Patients | Percentage |
|---|---|---|
| Expense | 1 |
Duration
Stopped taking Lifitegrast ophthalmic solution
| Duration | Patients | Percentage |
|---|---|---|
| 1 - 6 months | 1 | |
| 5 - 10 years | 1 |
What people switch to and from
Patients started taking Lifitegrast ophthalmic solution after stopping:
| Treatment | Patients | Percentage |
|---|---|---|
| Cyclosporine ophthalmic (Restasis) | 6 |
Patients stopped taking Lifitegrast ophthalmic solution and switched to:
| Treatment | Patients | Percentage |
|---|---|---|
| Cyclosporine ophthalmic (Restasis) | 2 |
Last updated: